Healthcare

Opthea Restructures Strategy Following Clinical Trial Setbacks
April 10, 2025 11:30 AM AEST| By Team Kalkine MediaHighlights,Opthea discontinues late-stage clinical studies after failing to meet drug efficacy benchmarks,Significant workforce downsizing initiated to realign operations and preserve resources,Company engages in discussions with backers while tradin...

Melanie Farris Joins (ASX:PTX) Prescient Therapeutics Board to Enhance Governance and Strategy
April 10, 2025 11:24 AM AEST| By Team Kalkine MediaHighlights,Melanie Farris,appointed,as non-executive director at Prescient Therapeutics.,Farris to spearhead audit and risk committee, bolstering board oversight.,(PTX) Prescient continues to advance its precision oncology trials.,Prescient Therapeut...

Expanding Horizons: Osteopore (ASX:OSX) Gains European Approval for Custom Implants
April 09, 2025 03:51 PM AEST| By Team Kalkine MediaHighlights,Osteopore (OSX) receives European approval for specialized implants.,Projected growth driven by demand in cranial and orthopaedic markets.,Exclusive distribution partnership established with Zimmer Biomet.,Osteopore (ASX:OSX), a pioneer in...

Expanding Horizons: Osteopore Gains Vital EU Approval for Custom Implants
April 09, 2025 03:39 PM AEST| By Team Kalkine MediaHighlights,Osteopore (OSX) receives critical EU MDR approval for its tailored implants.,The approval paves the way for growth in the European custom implant markets.,Strategic partnership opportunities, including with Zimmer Biomet, are set to expand...

Unveiling Sonic Healthcare's Financial Landscape in 2025: A Comprehensive Overview
April 09, 2025 02:23 PM AEST| By Team Kalkine MediaHighlights,SHL's revenue shows steady growth with a modest CAGR of 0.8% over the last three years.,Sonic Healthcare (SHL) experiences a significant shift in profitability and debt management.,Current valuation suggests SHL shares may be trading below...

Biotech stocks that withstood the challenges of April 2 are now facing the pressure of Trump's latest pharmaceutical threat.
April 09, 2025 01:30 PM AEST| By Team Kalkine MediaHighlights:,CSL Ltd (ASX:CSL), Mesoblast (ASX:MSB), and Cochlear Ltd (ASX:COH) have seen shifts in share performance following tariff-related developments.,The healthcare sector emerged as the worst performer on the ASX 200 after renewed uncertainty...

Market Impact: New U.S. Tariffs to Affect Pharmaceutical Sector
April 09, 2025 12:56 PM AEST| By Team Kalkine MediaHighlights,President Trump announces new tariffs on pharmaceuticals.,(CSL) shares fall following tariff news.,U.S. trade policies could reshape global pharmaceutical trade dynamics.,In a recent development that could significantly impact the pharmace...

Orthocell Gains Ground: Brazilian Market Entry to Boost Global Presence
April 09, 2025 12:55 PM AEST| By Team Kalkine MediaHighlights,Orthocell,(OCC) approved for Striate+ in Brazil.,Strategic entry into a $65 million market.,Planned expansion across Latin America.,Orthocell (ASX:OCC), an innovator in regenerative medicine, has successfully obtained regulatory approval f...

Transurban Group's (ASX:TCL) Steady Climb: A Look at Its Current Position and Future Prospects
April 09, 2025 12:48 PM AEST| By Team Kalkine MediaHighlights,(TCL) has,witnessed,a 1.0% rise since the beginning of 2025.,Offers a compelling dividend yield of 4.57%, higher than its 5-year average.,Positioned to,benefit,from consistent government infrastructure spending and population growth.,Trans...

Insider Confidence in Amplia Therapeutics Despite Market Fluctuations
April 09, 2025 11:47 AM AEST| By Team Kalkine MediaHighlights,Significant insider purchases reflect confidence in (ATX).,Recent,market value decline challenges,initial,optimism.,Insider ownership suggests long-term commitment to company growth.,Over the past year, insiders of Amplia Therapeutics Limi...

Pro Medicus (ASX:PME) Gains Momentum Amid Market Volatility: Analyst Upgrade Highlights
April 08, 2025 03:16 PM AEST| By Team Kalkine MediaHighlights,Pro Medicus receives upgrade to overweight status.,Shares bounce back with a 6% increase.,Unchanged price target reflects ongoing confidence.,In a recent market update, Pro Medicus (ASX:PME), a leading health imaging software provider, has...

Impressive Growth in Occupancy Sales Drives Summerset Group's Q1 Momentum
April 08, 2025 02:28 PM AEST| By Team Kalkine MediaHighlights,Robust Sales Growth,: Summerset achieves a 14% year-over-year increase in Q1 2025.,Geographic Expansion,: Sales flourish across diverse New Zealand regions.,Future Developments,: Expansion plans include new homes and a village center in Au...

Cochlear poised to avoid tariffs as countries begin negotiations with Trump
April 08, 2025 11:30 AM AEST| By Team Kalkine MediaHighlights:,Cochlear Limited aligns with international trade classifications to maintain duty-free access for hearing implants.,Recent tariff developments underscore the importance of regulatory frameworks in the global medical device landscape.,Key...

Why the Drop in Aroa Biosurgery Limited's (ASX:ARX) Share Price Shouldn't Surprise Investors
April 08, 2025 10:31 AM AEST| By Team Kalkine MediaHighlights,Aroa Biosurgery (ARX) shares drop 26% in 30 days.,P/S ratio stands at 1.8x, under industry average.,Future growth projections fall below industry trends.,Aroa Biosurgery Limited, trading under the ticker,(,ASX:ARX),, has witnessed a signif...

ASX Healthcare Stock Trading Well Below Pandemic Highs with Consistent Dividends
April 07, 2025 04:35 PM AEST| By Team Kalkine MediaHighlights,Healthcare group Sonic Healthcare has seen a significant decline from its peak during the pandemic,The company operates internationally, offering pathology and diagnostic services,It has delivered consistent dividend growth across many yea...

Mach7 Technologies Faces Market Pressure Amid Sluggish Growth Outlook
April 07, 2025 04:33 PM AEST| By Team Kalkine MediaHighlights,Mach7 Technologies has experienced a notable share price drop in recent weeks,The company’s price-to-sales ratio trails the broader healthcare services sector,Revenue growth expectations remain below industry projections,Mach7 Technologies...

Atomo Diagnostics (ASX:AT1) Broadens Reach with Major Initiatives in Australia and New Zealand
April 07, 2025 01:31 PM AEST| By Team Kalkine MediaHighlights,Expansion in Australia,:,Atomo,Diagnostics rolls out free HIV self-tests across Australia.,Launch in New Zealand,: Introduction of HIV self-test kits through Chemist Warehouse.,Executive Insight,: CEO emphasizes the importance of accessibi...

Exploring Regis Healthcare's (ASX:REG) Revenue Growth and Market Position
April 07, 2025 01:29 PM AEST| By Team Kalkine MediaHighlights,Exceptional Revenue Growth,: Regis Healthcare (REG) has shown impressive revenue growth trends over recent years.,Comparative P/S Ratio,: Its price-to-sales ratio aligns closely with the industry average, despite higher growth forecasts.,h...

Exploring Alcidion Group's Path to Profitability: A Closer Look at Its Strategic Progress
April 07, 2025 11:20 AM AEST| By Team Kalkine MediaHighlights,Alcidion,Group (ALC) nears its breakeven point.,Projected to turn a profit by 2026 based on current growth forecasts.,Unique,position with no debt enhances financial stability.,Alcidion Group (ASX:ALC), a key player in healthcare technolog...

Research reveals that Nyrada's leading medication can avert secondary brain injury.
April 07, 2025 10:30 AM AEST| By Team Kalkine MediaHighlights:,Nyrada Inc has released new findings from a study showing its drug candidate NYR-BI03 demonstrates neuroprotective effects following traumatic brain injury.,The research, conducted with the University of Sydney, Walter Reed Army Institute...

Advertise your brand on Kalkine Media